Catalyst Wire Dossier Catalyst Wire Dossier

Ambroxol hydrochloride lozenge

Ambroxol hydrochloride · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ambroxol hydrochloride lozenge, covering 2014-07-18 to 2014-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers [Phase 1]

See pricing